The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care. Read More >>
prostate cancer
June 2, 2019 · Monika Sharda, ASCO staff
February 11, 2019 · Greg Guthrie, ASCO Staff
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer. Read More >>
January 17, 2019 · Carol Michaels, MBA, ACE, ACSM
Exercise can greatly improve the physical and mental health of men with prostate cancer. Exercise specialist Carol Michaels shares what the benefits are and how to start a program that’s right for you. Read More >>
January 8, 2019 · Greg Guthrie, ASCO staff
In this podcast, Dr. Brian Rini and Dr. Jorge Garcia discuss the latest research in genitourinary cancers presented at the 2018 ESMO Congress. Read More >>
December 27, 2017 · Anne Katz, PhD, RN, FAAN
After androgen-deprivation therapy for prostate cancer, many couples are surprised by the physical and emotional changes that come into their relationship because of a lack of testosterone. Read More >>